Predicting survival of cancer patients by chromosomal copy number heterogeneity

Tom van den Bosch; Erik van Dijk; Louis Vermeulen; Daniël M. Miedema

doi:https://doi.org/10.1080/23723556.2021.1949956

Predicting survival of cancer patients by chromosomal copy number heterogeneity

Tom van den Bosch, Erik van Dijk, Louis Vermeulen, Daniël M. Miedema

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

Original language	English
Article number	1949956
Journal	Molecular & cellular oncology
Early online date	2021
DOIs	https://doi.org/10.1080/23723556.2021.1949956
Publication status	E-pub ahead of print - 2021

Keywords

Biomarker
chromosomal instability
intra-tumor heterogeneity
pan-cancer

Access to Document

https://doi.org/10.1080/23723556.2021.1949956

Cite this

@article{d0d2e5a99b204928808b4cc77990882e,

title = "Predicting survival of cancer patients by chromosomal copy number heterogeneity",

abstract = "We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.",

keywords = "Biomarker, chromosomal instability, intra-tumor heterogeneity, pan-cancer",

author = "{van den Bosch}, Tom and {van Dijk}, Erik and Louis Vermeulen and Miedema, {Dani{\"e}l M.}",

note = "Publisher Copyright: {\textcopyright} 2021 Taylor & Francis Group, LLC.",

year = "2021",

doi = "https://doi.org/10.1080/23723556.2021.1949956",

language = "English",

journal = "Molecular & cellular oncology",

issn = "2372-3548",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Predicting survival of cancer patients by chromosomal copy number heterogeneity

AU - van den Bosch, Tom

AU - van Dijk, Erik

AU - Vermeulen, Louis

AU - Miedema, Daniël M.

PY - 2021

Y1 - 2021

N2 - We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

AB - We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.

KW - Biomarker

KW - chromosomal instability

KW - intra-tumor heterogeneity

KW - pan-cancer

UR - http://www.scopus.com/inward/record.url?scp=85111977258&partnerID=8YFLogxK

U2 - https://doi.org/10.1080/23723556.2021.1949956

DO - https://doi.org/10.1080/23723556.2021.1949956

M3 - Article

C2 - 34616875

SN - 2372-3548

JO - Molecular & cellular oncology

JF - Molecular & cellular oncology

M1 - 1949956

ER -

Predicting survival of cancer patients by chromosomal copy number heterogeneity

Abstract

Keywords

Access to Document

Other files and links

Cite this